11 Cheap ESG Stocks to Buy According to Hedge Funds
These days, it seems like everyone wants to wear the “saving the world” cape.
Elevance Health Inc. (ELV)
Market is closed
Sector: Hospital & Medical Service Plans
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period: Filing is Ongoing
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Yacktman Asset Management Donald Yacktman | 342,468 | $148,959,881 | +1% | 1.96% |
| 2. | High Ground Investment Management Edgar Allen | 222,030 | $96,574,168 | +7% | 22.55% |
| 3. | Pzena Investment Management Richard S. Pzena | 200,980 | $87,418,261 | +4% | 0.31% |
| 4. | Iridian Asset Management David Cohen And Harold Levy | 51,991 | $22,614,005 | -14% | 7.09% |
| 5. | Impax Asset Management Ian Simm | 28,670 | $12,470,303 | +13% | 0.08% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $384.36 | 1,300 | Director | 4,714 | 2021-07-23 | Filing | |
| $296.03 | 1,700 | Director | 2,921 | 2021-02-04 | Filing | |
| $264.22 | 2,000 | Officer, Director | 26,556 | 2020-01-30 | Filing | |
| $263.52 | 5,600 | Officer, Director | 24,556 | 2020-01-30 | Filing | |
| $57.30 | 144 | Officer | 61,025 | 2010-12-02 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $424.82 | 4,588 | Officer | 18,977 | 2025-04-24 | Filing | |
| $415.13 | 443 | Officer | 1,847 | 2025-03-10 | Filing | |
| $396.30 | 3,504 | Officer | 10,116 | 2025-03-05 | Filing | |
| $432.14 | 7,417 | Officer | 8,423 | 2024-10-18 | Filing | |
| $531.52 | 753 | Director | 8,744 | 2024-08-05 | Filing |
Institutional Investors' Holdings
Filing Period: Filing is Ongoing
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 21,311,015 | $9,269,439,181 | 0.19% | |
| 2. | 2,426,828 | $1,055,573,106 | 0.35% | |
| 3. | 2,303,038 | $1,001,729,409 | 0.87% | |
| 4. | 1,405,073 | $611,150,662 | 0.12% | |
| 5. | 849,454 | $369,478,512 | 0.26% |
News See All
10 Best Stocks to Buy According to D1 Capital's Daniel Sundheim
Daniel Sundheim is the founder and chief investment officer of D1 Capital Partners, a global investment firm active across both public and private markets.
Is Elevance (ELV) an Attractively Valued Stock?
Madison Investments, an investment advisor, released its “Madison Large Cap Fund” first-quarter 2025 investor letter. A copy of the letter can be downloaded here.
Elevance Health Inc. (NYSE:ELV) Q1 2025 Earnings Call Transcript
Operator: Ladies and gentlemen, thank you for standing by and welcome to the Elevance Health First Quarter Earnings Conference Call. At this time, all participants are in a listen-only mode.
10 Best Stocks That Will Always Grow
Threats of an impending recession are looming over the stock market due to Trump's tariffs and macroeconomic uncertainty.
Top 20 Falling Stocks with Unusual Volume
Uncertainty around tariffs and macroeconomic conditions has dented investor confidence, resulting in stock prices falling.
10 Best Telehealth Stocks to Buy Now
According to Grand View Research, the telehealth market size in the US was valued at $42.54 billion in 2024.
10 Best Medical Stocks to Buy According to Billionaires
Some experts view medical, healthcare, and big pharma stocks as immune from trade carnage, making them a safe haven amid the uncertainty brought about by Trump's tariffs.
Elevance Health (ELV) is Rebounding From Sell Off
GreensKeeper Asset Management, an investment management company, released its first quarter 2025 investor letter. A copy of the letter can be downloaded here.
Here’s Why Elevance Health (ELV) Declined in Q4
Hotchkis & Wiley, an investment management company, released its “Hotchkis & Wiley Large Cap Fundamental Value Fund” fourth quarter 2024 investor letter.
Billionaire Hedge Funds
